Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: Cgc | Vintage Vibes

10 Greatest and Most Undervalued Key Comics You Should Snatch Up Now

Some of the most underrated and undervalued key comics are not #1 issues. They don’t always feature the first appearances of major characters. Some key comics fall under the radar and are not seen for having the value they should really have. These are key comics you should snatch up…

Personal Finance Advice

NSW emerges as main loser from GST carve-up as WA gets extra $5.5bn

NSW premier says latest distribution calculation, with a reduction in the state’s share of revenue relative to its population, is unfair and ‘past its use-by date’

The Guardian - AU

The 8 Most Underrated Female First‑Appearance Key Comics — Invest Before the Market Catches On

Key comics are comic books that are historically important to comic book industry fans and collectibles experts. The first appearances of Superman, Batman, or Spider-Man are key comics. The first time that major Marvel characters like Iron Man, Thor, and the Hulk combine to form the Avengers is a key…

Personal Finance Advice

From analysis to the latest developments in health,
read the most diverse news in one place.

8 Affordable Collectible Comics Investors Should Add to Their Portfolio

There is a wide line between a comic book collector and a collectibles investor. 20 years ago, you really had to be in the know and have connections to be a collectibles investor. Now, all you need to do is visit a website with a price guide to check the…

Personal Finance Advice

Investment Superpowers: 10 Best Comics to Invest in 2026 Right Now

Comic book collectibles can be a risky investment. The collectibles market is volatile, and there is no index or stock market-like system for quantifying value. Still, some comic books are sure bets for investment relative to others. Here are 10 of the best comics to invest in 2026 right now.…

Personal Finance Advice

Canopy Growth Is Surging and Analysts Still Think It Can Gain 40% from Here

Canopy Growth soars on reports the White House is considering reclassifying cannabis as a “Schedule III” drug. Here’s why CGC shares currently look attractive as a long-term holding.

Barchart

Preserve, Protect, Profit: The 6 Best Comic Book Grading and Slabbing Companies

There is a process to convincing someone else, usually a stranger, to buy what you own. Many people have Antiques Roadshow or Pawn Stars syndrome; they think they will trip over crap in the attic and find out it’s priceless. There are processes to follow if you want to sell…

Personal Finance Advice

Read news from The Economist, FT, and more,
with one subscription

Comics Royalty: The 100 Most Valuable Comic Books Collectors Should Seek

In my previous articles about valuable comic books, I have primarily focused on comic books that have sold at auction for hundreds of thousands and millions of dollars. So, in this list of the 100 most valuable comic books, I have focused on comic books that stand to gain more…

Personal Finance Advice

Superheroes, Scarcity & Serious Value: The Top 25 Most Valuable Comic Books

It’s easy to forget that the lion’s share of modern comic book fans are “casuals” or “normies.” The biggest modern comic book fans don’t read comic books. They know nothing about source material comics. Instead of being a cranky old guy yelling at clouds, I want to tell you about…

Personal Finance Advice

Canopy Growth (CGC) Stock Is Falling Wednesday: What's Going On?

Shares of Canopy Growth Corp (NASDAQ:CGC) are trading lower Wednesday, pulling back from a sharp rally on Monday. The stock is seeing a downturn as initial excitement wanes following a social media post by President Donald Trump over the weekend that lifted the entire cannabis sector.

Benzinga

As Trump Promotes CBD, Should You Buy, Sell, or Hold Canopy Growth Stock?

Canopy Growth stock rallies as President Donald Trump says cannabis could prove transformative for senior healthcare. But CGC shares remain unattractive to own in 2025.

Barchart

Is Canopy Growth Stock a Buy, Sell, or Hold for September 2025?

Should investors buy, sell, or hold CGC stock after its recent stock resurgence?

Barchart

While Investors Chase Monday's Tilray, Canopy And Aurora Rally, A Potential Federal Shift Could Redefine Cannabis Growth Fundamentals

Shares of major cannabis companies, including Tilray Brands Inc (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), and Aurora Cannabis Inc (NASDAQ:ACB), are trading sharply higher Monday morning.

Benzinga

Adult-Use Cannabis Boom Powers Canopy Growth Sales, But Wider Loss Hits Margins

Canopy Growth Corporation (NASDAQ:CGC) reported its first-quarter 2026 financial results on Friday, announcing a wider-than-expected loss despite surpassing revenue forecasts.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Personal Finance Advice

Silver Age Icons: The Most Valuable Comic Books of the 1960s

Some of the most valuable comic books of the 1960s were the inspirations for the billion-dollar comic book movies we all love now. This was the Silver Age of comic books. Comic book characters like Spider-Man, the X-Men, the Fantastic Four, and the Avengers made their debut during this era.

Benzinga

Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Know

Canopy USA, LLC has wrapped up its acquisition of Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), Canopy Growth Corporation's (TSX: WEED) (NASDAQ: CGC) U.S.-domiciled holding company said on Monday. Canopy USA, created in 2022 to streamline the Canadian cannabis giant's entry into the US market, now owns 100% of…

Benzinga

Canopy Growth Names New CEO Who Will Succeed David Klein Amid US Expansion

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced on Tuesday its board of directors has named Luc Mongeau as the company's next chief executive officer, effective Jan. 6, 2025.Mongeau, a CPG veteran and current board member at the Canadian cannabis giant, succeeds CEO David Klein, who announced his plans to…

Al Jazeera

Why boarding schools for toddlers are gaining popularity in Lesotho

As many parents migrate for job opportunities, children are left with relatives, nannies, and more recently at schools.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Two pilots survive light aircraft crash on busy road in Gloucestershire

Both men escape without serious injury after aircraft crash-lands on A-road near Cotswold Gliding Club

PC Gamer

Magic's most-valuable card hits an absurd $3 million after 'private sale', some call shenanigans, no one knows what's real, but what's true is it was bought with bitcoin

The Alpha Black Lotus is now the single most valuable card in existence.

Barchart

Up 100% YTD, Is Canopy Growth Stock Overbought?

Canopy Growth stock has surged over 100% in 2024. Despite its recent gains, CGC stock remains a high-risk bet, due to its weak fundamentals and negative profit margins.

The Guardian - UK

‘We can’t hunt or fish’: the villages in Ecuador’s Amazon surrounded by abandoned explosives

In 2002, high explosives were laid in oil wells across 20 sq km of forest. The firm has gone but the pentolite remains, despite a court ruling, putting lives and the ecosystem at risk

StockNews.com

Canopy Growth (CGC) vs. Novo Nordisk (NVO): Which Pharma Stock Is a Better Investment?

The Pharma sector’s innovative trial methodologies and shift toward customized medicine signal transformative growth potential in the pharmaceutical industry. While leading Pharma stocks Canopy Growth (CGC) and Novo Nordisk (NVO) stand to benefit, let us analyze which of them is a better investment.

Barchart

Why Are Canopy Growth (CGC) Options Soaring? It’s Politics, Baby!

It’s important to deal with reality. CGC stock is soaring because of election implications, not because the financials are so robust.

StockNews.com

Pharma Buy, Hold, or Sell: 4 Stocks Worth Considering

The pharmaceutical industry is anticipated to thrive as demand grows and technology advances. However, given the macroeconomic uncertainties, let us analyze leading pharma stocks Zoetis (ZTS), Verano Holding (VRNOF), Canopy Growth (CGC) and SNDL (SNDL) to identify whether they are a Buy, Hold, or Sell. Read on.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.